These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27679422)

  • 21. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
    Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
    J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between red blood cell distribution and islet β-cell function indexes in patients with type 2 diabetes.
    Zhang D; Zhang S; Wang L; Pan T; Zhong X
    BMC Endocr Disord; 2021 Jan; 21(1):7. PubMed ID: 33413319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.
    Jacob S; Rabbia M; Meier MK; Hauptman J
    Diabetes Obes Metab; 2009 Apr; 11(4):361-71. PubMed ID: 19207292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus.
    Dullaart RP; Annema W; de Boer JF; Tietge UJ
    Atherosclerosis; 2012 Jun; 222(2):567-73. PubMed ID: 22541874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
    Anholm C; Kumarathurai P; Pedersen LR; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
    Diabetes Obes Metab; 2017 Jun; 19(6):850-857. PubMed ID: 28124822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function.
    Torres-Rasgado E; Porchia LM; Ruiz-Vivanco G; Gonzalez-Mejia ME; Báez-Duarte BG; Pulido-Pérez P; Rivera A; Romero JR; Pérez-Fuentes R
    Metab Syndr Relat Disord; 2015 Feb; 13(1):45-51. PubMed ID: 25423015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different Analysis of
    Duan Y; Sun X; Liu J; Fu J; Wang G
    J Diabetes Res; 2019; 2019():6053604. PubMed ID: 31772943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment.
    Parkinson J; Hamrén B; Kjellsson MC; Skrtic S
    Br J Clin Pharmacol; 2016 Dec; 82(6):1613-1624. PubMed ID: 27450071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
    BMJ; 1995 Jan; 310(6972):83-8. PubMed ID: 7833731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetes.
    Wilkins JJ; Dubar M; Sébastien B; Laveille C
    J Clin Pharmacol; 2014 Mar; 54(3):267-78. PubMed ID: 24122776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive deterioration of β-cell function in obese youth with type 2 diabetes.
    Bacha F; Gungor N; Lee S; Arslanian SA
    Pediatr Diabetes; 2013 Mar; 14(2):106-11. PubMed ID: 22913617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial.
    Parthan G; Bhansali S; Kurpad AV; Walia R; Bhat K; Bhansali A
    BMC Pharmacol Toxicol; 2018 Jul; 19(1):38. PubMed ID: 29970184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults.
    Elder DA; Prigeon RL; Wadwa RP; Dolan LM; D'Alessio DA
    J Clin Endocrinol Metab; 2006 Jan; 91(1):185-91. PubMed ID: 16263830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.